01Application
Enough context to decide whether a conversation is worth having. The diligence folder comes later.

If the requirement fits the network, Provenance will respond within two business days with the next verification step. No public listing. No listing fee.
For licensed importers, wholesalers, distributors, pharmaceutical companies, processors, and other institutional buyers in regulated medical markets.
Four progressive steps designed for licensed operators navigating regulated medical-cannabis markets.
01Enough context to decide whether a conversation is worth having. The diligence folder comes later.
02Provenance reviews corporate licenses, jurisdictional authority, and operational credibility.
03Qualified parties move through verification and an appropriate confidentiality process.
04Approved parties receive relevant introductions and controlled document exchanges.
Provenance does not publish inventory or expose counterparties. The initial screen identifies whether a requirement is specific enough to enter controlled verification.
A website claim is not a license check. Sensitive commercial information stays private until there is a reason to share it.
Supplier and buyer identities are not publicly exposed. Qualified introductions are structured around commercial fit, authority, and appropriate fee protection.
Licenses, certificates, capacity, product specifications, COAs, and processing pathways are checked before a lead is treated as transaction-ready.
Provenance maintains a private pipeline of qualified suppliers, buyers, processors, and market-access partners. Sensitive names, pricing, and diligence materials remain gated.
NDA and verification requiredProvenance helps counterparties surface the documents, authorities, and commercial constraints that determine whether an opportunity is real.
Latin American GACP cultivation feeding European pharmaceutical channels through an approved EU-GMP pathway.
Buyers can request a private, non-binding supply screen. Suppliers can apply separately. We ask for enough to judge fit, then request technical materials through a controlled channel.
Private reviewYour information is never turned into a public listing.
02Direct responseQualified applicants hear from Provenance directly.
03No listing feeCommercial terms are discussed only after fit is established.
For licensed importers, wholesalers, distributors, product sponsors, pharmaceutical companies, and processors with a current or planned requirement.
The essentials for licensed operators evaluating Provenance.
Ask a different question ↗Provenance is a compliance-first commercial origination network for international medical cannabis trade. We qualify licensed counterparties, structure protected introductions, and organize the information needed to evaluate cross-border opportunities.
For licensed operators, institutional partners, service providers, and inquiries outside the supplier and buyer application flow.
Get in touch ↗